{
  "source": "MFN",
  "fetcher_build": "2026-08-03-nasdaq-fallback-calendar-v5",
  "status": "resolved_no_reports",
  "resolution": {
    "status": "resolved",
    "company_name": "Swedish Orphan Biovitrum",
    "expected_name": "Swedish Orphan Biovitrum AB",
    "match_score": 100.0,
    "slug": "swedish-orphan-biovitrum",
    "url": "https://mfn.se/all/a/swedish-orphan-biovitrum",
    "metadata": {
      "country": "Sverige",
      "list": "Large Cap Stockholm",
      "sector": "Hälsovård",
      "industry": "Läkemedel & Handel",
      "website": "https://mb.cision.com/Main/14266/4379300/4207474.pdf"
    },
    "ticker_candidates": [],
    "attempts": [
      {
        "slug": "swedish-orphan-biovitrum-ab",
        "url": "https://mfn.se/all/a/swedish-orphan-biovitrum-ab",
        "status": "identity_mismatch",
        "title": "",
        "score": 0.0
      }
    ]
  },
  "releases": [],
  "skipped_because_nasdaq": [
    {
      "report_key": "2026:q2",
      "title": "Delårsrapport för andra kvartalet 2026: Betydande tillväxt med viktiga framsteg i pipeline",
      "date": "2026-07-16",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/delarsrapport-for-andra-kvartalet-2026-betydande-tillvaxt-med-viktiga-framsteg-i-pipeline-417f07f9"
    },
    {
      "report_key": "2026:q1",
      "title": "Swedish Orphan Biovitrum AB: Delårsrapport för första kvartalet 2026: Stark leverans och viktiga framsteg i pipeline",
      "date": "2026-04-28",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/swedish-orphan-biovitrum-ab-delarsrapport-for-forsta-kvartalet-2026-stark-leverans-och-viktiga-framsteg-i-pipeline-1ab6c0e9"
    },
    {
      "report_key": "2025:q4",
      "title": "Swedish Orphan Biovitrum AB: Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2025: Året avslutas med betydande tillväxt och strategiska framsteg",
      "date": "2026-02-05",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/swedish-orphan-biovitrum-ab-sobi-publicerar-delarsrapport-for-fjarde-kvartalet-och-bokslutskommunike-for-2025-aret-avslutas-med-betydande-tillvaxt-och-strategiska-framsteg-71a67211"
    },
    {
      "report_key": "2025:q4",
      "title": "Swedish Orphan Biovitrum AB: Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress",
      "date": "2026-02-05",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/swedish-orphan-biovitrum-ab-sobi-q4-and-fy-2025-report-closing-the-year-with-significant-growth-and-strategic-progress-237223b6"
    },
    {
      "report_key": "2025:q3",
      "title": "Swedish Orphan Biovitrum AB: Sobi publicerar delårsrapport för tredje kvartalet 2025: Accelererad tillväxt och momentum i portföljen",
      "date": "2025-10-20",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/swedish-orphan-biovitrum-ab-sobi-publicerar-delarsrapport-for-tredje-kvartalet-2025-accelererad-tillvaxt-och-momentum-i-portfoljen-780158da"
    },
    {
      "report_key": "2025:q3",
      "title": "Swedish Orphan Biovitrum AB: Sobi meddelar reviderade helårsutsikter och tidigarelägger publiceringen av delårsrapporten för tredje kvartalet 2025",
      "date": "2025-10-19",
      "url": "https://mfn.se/cis/a/swedish-orphan-biovitrum/swedish-orphan-biovitrum-ab-sobi-meddelar-reviderade-helarsutsikter-och-tidigarelagger-publiceringen-av-delarsrapporten-for-tredje-kvartalet-2025-5f0d0ebc"
    }
  ],
  "metadata": {
    "country": "Sverige",
    "list": "Large Cap Stockholm",
    "sector": "Hälsovård",
    "industry": "Läkemedel & Handel",
    "website": "https://mb.cision.com/Main/14266/4379300/4207474.pdf"
  },
  "ticker_candidates": [],
  "company_url": "https://mfn.se/all/a/swedish-orphan-biovitrum",
  "company_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\mfn\\company.txt",
  "company_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\mfn\\company.html"
}